Cambrian Bioworks at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Cambrian Bioworks brings 1 presentation to ASHG 2026 in Montréal, and exhibits at Booth 1708. Its program centres on rare disease, cancer, and clinical genetics. Cambrian Bioworks brings genome-resolved gut resistome profiling using long-fragment enrichment.

Organization

ASHG 2026 Attendance

Cambrian Bioworks

Dover, Delaware

1 Product Manager (Genomics R&D)

cambrianbioworks.com

Private company

Cambrian Bioworks sells automated nucleic-acid extraction systems, magnetic-bead kits, and library-preparation reagents to clinical and research laboratories.

Manta receives CE-IVD certification for clinical diagnostics (2025-06)

›

Manta receives CE-IVD certification for clinical diagnostics · 2025-06-05

“Cambrian Bioworks is proud to announce that Manta, its fully automated nucleic acid extraction platform, has received CE-IVD certification under Regulation (EU) 2017/746 (IVDR).”

Source: company newsroom

Raised $1.45M (Seed, 2024-07)

›

$1.45 million seed funding, announced July 15, 2024; led by the Irani Family Office. · 2024-07-15

“We’ve raised $1.45 million in seed funding! This round was led by the Irani Family Office.”

Source: funding announcement

Currently hiring: 1 open roles

›

Source: careers page

Booth

Exhibiting at Booth 1708

Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm